Dow Up 0.64% Nasdaq Up 0.68%

Alkermes plc (ALKS)

-NasdaqGS
46.10 Up 0.92(2.04%) 4:00PM EDT
|After Hours : 46.10 0.00 (0.00%) 5:11PM EDT
Prev Close:45.18
Open:45.24
Bid:37.73 x 600
Ask:51.48 x 100
1y Target Est:50.92
Beta:1.57
Next Earnings Date:N/A
Day's Range:45.24 - 46.20
52wk Range:29.36 - 54.25
Volume:807,307
Avg Vol (3m):759,666
Market Cap:6.72B
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALKS

Comparison

Symbol% ChgMkt Cap
ALKSUp 2.04%6.72B
ABTUp 0.71%65.70B
LLYUp 1.03%71.36B
GSKUp 0.40%113.59B

Key Statistics

Forward P/E (1 yr):76.83
P/S (ttm):11.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.27
Quarterly EPS Est (Sep-14) :0.02
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):12.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback